Guanhao Biotech Co.,Ltd.

XSEC:300238 Stock Report

Market Cap: CN¥3.7b

Guanhao BiotechLtd Balance Sheet Health

Financial Health criteria checks 6/6

Guanhao BiotechLtd has a total shareholder equity of CN¥471.1M and total debt of CN¥84.1M, which brings its debt-to-equity ratio to 17.8%. Its total assets and total liabilities are CN¥730.3M and CN¥259.2M respectively. Guanhao BiotechLtd's EBIT is CN¥9.4M making its interest coverage ratio -12.1. It has cash and short-term investments of CN¥106.6M.

Key information

17.8%

Debt to equity ratio

CN¥84.08m

Debt

Interest coverage ratio-12.1x
CashCN¥106.65m
EquityCN¥471.07m
Total liabilitiesCN¥259.25m
Total assetsCN¥730.32m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 300238's short term assets (CN¥273.6M) exceed its short term liabilities (CN¥164.3M).

Long Term Liabilities: 300238's short term assets (CN¥273.6M) exceed its long term liabilities (CN¥95.0M).


Debt to Equity History and Analysis

Debt Level: 300238 has more cash than its total debt.

Reducing Debt: 300238's debt to equity ratio has reduced from 25.2% to 17.8% over the past 5 years.

Debt Coverage: 300238's debt is well covered by operating cash flow (31.6%).

Interest Coverage: 300238 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies